These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16254698)

  • 21. Inflammation, demyelination, and degeneration - recent insights from MS pathology.
    Stadelmann C; Wegner C; Brück W
    Biochim Biophys Acta; 2011 Feb; 1812(2):275-82. PubMed ID: 20637864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
    Mühlau M; Buck D; Förschler A; Boucard CC; Arsic M; Schmidt P; Gaser C; Berthele A; Hoshi M; Jochim A; Kronsbein H; Zimmer C; Hemmer B; Ilg R
    Mult Scler; 2013 Oct; 19(11):1485-92. PubMed ID: 23462349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].
    Zivadinov R; Sepcić J
    Lijec Vjesn; 2006; 128(9-10):295-308. PubMed ID: 17128669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.
    Vercellino M; Masera S; Lorenzatti M; Condello C; Merola A; Mattioda A; Tribolo A; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
    J Neuropathol Exp Neurol; 2009 May; 68(5):489-502. PubMed ID: 19525897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Demyelinating lesions in the cervical cord in multiple sclerosis 10 years after onset of the disease. Correlation between MRI parameters and clinical course.
    Bonek R; Orlicka K; Maciejek Z
    Neurol Neurochir Pol; 2007; 41(3):229-33. PubMed ID: 17629816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progressive multiple sclerosis and gray matter pathology: an MRI perspective.
    Inglese M; Oesingmann N; Casaccia P; Fleysher L
    Mt Sinai J Med; 2011; 78(2):258-67. PubMed ID: 21425269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenesis of brain and spinal cord atrophy in multiple sclerosis.
    Minagar A; Toledo EG; Alexander JS; Kelley RE
    J Neuroimaging; 2004 Jul; 14(3 Suppl):5S-10S. PubMed ID: 15228754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CROP - The Clinico-Radiologico-Ophthalmological Paradox in Multiple Sclerosis: Are Patterns of Retinal and MRI Changes Heterogeneous and Thus Not Predictable?
    Aboulenein-Djamshidian F; Krššák M; Serbecic N; Rauschka H; Beutelspacher S; Kukurová IJ; Valkovič L; Khan A; Prayer D; Kristoferitsch W
    PLoS One; 2015; 10(11):e0142272. PubMed ID: 26565967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis.
    Deppe M; Marinell J; Krämer J; Duning T; Ruck T; Simon OJ; Zipp F; Wiendl H; Meuth SG
    Neuroimage Clin; 2014; 6():475-87. PubMed ID: 25610761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gray matter involvement in multiple sclerosis.
    Pirko I; Lucchinetti CF; Sriram S; Bakshi R
    Neurology; 2007 Feb; 68(9):634-42. PubMed ID: 17325269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Multiple sclerosis: from the immune system to inflammatory demyelination and irreversible neurodegeneration].
    Sindic CJ
    Bull Mem Acad R Med Belg; 2002; 157(7-9):391-8; discussion 398-400. PubMed ID: 12647378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Axonal damage in multiple sclerosis: a complex issue in a complex disease.
    Grigoriadis N; Ben-Hur T; Karussis D; Milonas I
    Clin Neurol Neurosurg; 2004 Jun; 106(3):211-7. PubMed ID: 15177770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetisation transfer ratio in optic neuritis is associated with axonal loss, but not with demyelination.
    Klistorner A; Chaganti J; Garrick R; Moffat K; Yiannikas C
    Neuroimage; 2011 May; 56(1):21-6. PubMed ID: 21338694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis.
    Wang Y; Sun P; Wang Q; Trinkaus K; Schmidt RE; Naismith RT; Cross AH; Song SK
    Brain; 2015 May; 138(Pt 5):1223-38. PubMed ID: 25724201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review.
    Karussis D
    J Autoimmun; 2014; 48-49():134-42. PubMed ID: 24524923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.
    Dulamea AO
    Adv Exp Med Biol; 2017; 958():91-127. PubMed ID: 28093710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis.
    Brown RA; Narayanan S; Arnold DL
    Neuroimage Clin; 2014; 6():20-5. PubMed ID: 25610760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis.
    Peterson LK; Fujinami RS
    J Neuroimmunol; 2007 Mar; 184(1-2):37-44. PubMed ID: 17196667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathology of multiple sclerosis and related inflammatory demyelinating diseases.
    Kutzelnigg A; Lassmann H
    Handb Clin Neurol; 2014; 122():15-58. PubMed ID: 24507512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of white matter damage in animal models of multiple sclerosis by magnetization transfer ratio and quantitative mapping of the apparent bound proton fraction f.
    Rausch M; Tofts P; Lervik P; Walmsley A; Mir A; Schubart A; Seabrook T
    Mult Scler; 2009 Jan; 15(1):16-27. PubMed ID: 18971220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.